Dr. Philip Chan

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Cytosorbents Corp publishes a filing, an earnings call transcript or a press release.

Get CTSO alerts

About Dr. Philip Chan

Dr. Philip Chan is recorded as CEO at Cytosorbents Corp (CTSO). Dr. Philip Chan has spoken on 1 earnings call across 1 company, most recently for Cytosorbents Corp on March 25, 2026. Cytosorbents Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cytosorbents Corp includes Phillip Chan (CEO and Board Member), Alexander D'Amico (CFO), Kathleen Bloch (CFO) and 7 others.

Dr. Philip Chan on recent calls

“Before we begin, I'd like to point out our regulatory disclaimer on both Cytosorb and DrugSorb ATR. Cytosorbents is built around a differentiated blood purification platform designed to remove toxins and harmful substances from the bloodstream in critically ill patients.”

CEO, Cytosorbents Corp Q4 FY2025 Earnings Call · March 25, 2026